Valuation : Abbott Laboratories

Market Cap 176B 904B 152B 144B 130B 245B 16,854B 246B 1,705B 657B 8,567B 662B 648B 27,059B P/E 2026 *
28.9x
P/E 2027 * 22.4x
Enterprise Value 200B 1,027B 173B 164B 148B 278B 19,142B 280B 1,936B 746B 9,730B 752B 736B 30,731B EV / Sales 2026 *
3.99x
EV / Sales 2027 * 3.62x
Free-Float
86.16%
Yield 2026 *
2.52%
Yield 2027 * 2.69%
1 day-12.14%
1 week-5.70%
Current month-8.21%
1 month-8.46%
3 months+18.74%
6 months-7.78%
Current year-23.80%
1 week 43.27
Extreme 43.27
46.35
1 month 43.27
Extreme 43.27
50.35
Current year 33.5
Extreme 33.5
57.5
1 year 33.5
Extreme 33.5
61.82
3 years 33.5
Extreme 33.5
67.65
5 years 33.5
Extreme 33.5
67.65
10 years 10.4
Extreme 10.403333
67.65
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-12.14%-5.70% - - 176B
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -1.54%-5.08%+1.72%+8.60% 61.98B
Weighted average by Cap. -3.44%-4.90%-6.02%+10.83%

Financials

2026 *2027 *
Net sales 50.2B 257B 43.3B 40.98B 37.12B 69.61B 4,797B 70.08B 485B 187B 2,438B 188B 184B 7,701B 54.53B 280B 47.02B 44.5B 40.32B 75.6B 5,210B 76.12B 527B 203B 2,648B 205B 200B 8,364B
Net income 6.3B 32.32B 5.44B 5.14B 4.66B 8.74B 602B 8.8B 60.9B 23.48B 306B 23.66B 23.15B 967B 7.98B 40.9B 6.88B 6.51B 5.9B 11.06B 762B 11.14B 77.08B 29.72B 387B 29.95B 29.3B 1,224B
Net Debt 23.94B 123B 20.64B 19.54B 17.7B 33.19B 2,287B 33.42B 231B 89.18B 1,163B 89.87B 87.92B 3,672B 20.96B 107B 18.07B 17.1B 15.5B 29.06B 2,002B 29.25B 202B 78.07B 1,018B 78.67B 76.97B 3,215B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
11/09/26 R$43.71 -0.75% 318
10/09/26 R$44.04 -2.20% 70
09/09/26 R$45.03 -0.16% 7
08/09/26 R$45.10 -2.70% 320
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
101.95USD
Average target price
120.26USD
Spread / Average Target
+17.96%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!